Cargando…
Chemotherapy of advanced malignant teratomas.
Between 1977 and November 1979 we have treated 53 patients with malignant teratomas (43 males, 10 females). Thirty (70%) out of the 43 male patients had advanced and bulky disease at the time of presentation. Using different drug combinations in a sequential manner as described below, results are as...
Autores principales: | Newlands, E. S., Begent, R. H., Kaye, S. B., Rustin, G. J., Bagshawe, K. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010417/ https://www.ncbi.nlm.nih.gov/pubmed/7426343 |
Ejemplares similares
-
Response of differentiated but not anaplastic teratoma to interferon.
por: Rustin, G. J., et al.
Publicado: (1984) -
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989) -
Tumour-marker levels and prognosis in malignant teratoma of the testis.
por: Germa-Lluch, J. R., et al.
Publicado: (1980) -
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
por: Hitchins, R. N., et al.
Publicado: (1989) -
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
por: Smith, D. B., et al.
Publicado: (1990)